Pratik Shah

Insider Reports History

Location
3366 N. Torrey Pines Court, Suite 220, La Jolla, CA
Signature
/s/ Kathleen Scott, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pratik Shah:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Design Therapeutics, Inc. President, CEO and Chairperson, Director Stock option (right to buy) 600K Jan 2, 2025 Direct
ARS Pharmaceuticals, Inc. Director Stock Option (right to buy) 30K Jun 25, 2025 Direct

Insider Reports Filed by Pratik Shah

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SPRY ARS Pharmaceuticals, Inc. Jun 25, 2025 1 $0 4 Jun 27, 2025 Director
DSGN Design Therapeutics, Inc. Jan 2, 2025 1 $0 4 Jan 6, 2025 President, CEO and Chairperson, Director
SPRY ARS Pharmaceuticals, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
SPRY ARS Pharmaceuticals, Inc. Jun 13, 2024 2 $0 4 Jun 17, 2024 Director
SPRY ARS Pharmaceuticals, Inc. Jun 7, 2024 1 $0 4 Jun 7, 2024 Director, 10%+ Owner
SPRY ARS Pharmaceuticals, Inc. Jun 4, 2024 1 $0 4/A Jun 7, 2024 Director, 10%+ Owner
SPRY ARS Pharmaceuticals, Inc. Jun 4, 2024 3 $0 4 Jun 6, 2024 Director, 10%+ Owner
DSGN Design Therapeutics, Inc. Sep 1, 2023 3 $0 4 Sep 5, 2023 President, CEO and Chairperson, Director
SPRY ARS Pharmaceuticals, Inc. Jun 27, 2023 1 $0 4 Jun 28, 2023 Director, 10%+ Owner
DSGN Design Therapeutics, Inc. Feb 1, 2023 1 $0 4 Feb 3, 2023 Executive Chairperson, Director
SPRY ARS Pharmaceuticals, Inc. Nov 8, 2022 2 $0 4 Nov 10, 2022 Director, 10%+ Owner
SPRY ARS Pharmaceuticals, Inc. Nov 8, 2022 0 $0 3 Nov 10, 2022 Director, 10%+ Owner
DSGN Design Therapeutics, Inc. Feb 1, 2022 1 $0 4 Feb 2, 2022 Executive Chairperson, Director